Evaluating a Nonessential Amino Acid Restriction (NEAAR) Medical Food With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LARC) - Trial NCT06380101
Access comprehensive clinical trial information for NCT06380101 through Pure Global AI's free database. This phase not specified trial is sponsored by University of South Florida and is currently Recruiting. The study focuses on Rectal Cancer. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of South Florida
Timeline & Enrollment
N/A
Sep 08, 2023
Jun 01, 2025
Primary Outcome
Rate of CTCAE v5.0 non-hematological Grade 3 and higher diarrhea
Summary
This clinical study aims to assess feasibility, safety, tolerability, and compliance of a
 Nonessential Amino Acid Restriction (NEAAR) medical food in adult patients with locally
 advanced rectal cancer during standard of care short course radiotherapy followed by standard
 of care chemotherapy.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06380101
Non-Device Trial